Trial Profile
Compassionate use of nitazoxanide for the treatment of clostridium difficile colitis in patients who have failed conventional therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Clostridium difficile infections; Colitis
- Focus Therapeutic Use
- 14 Oct 2006 New trial record.